Skip to main content

Table 3 Evolution of the HFMS scores in the two SMA groups (type II and III) during the VPA treatment.

From: Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid

 

Evaluations

 

SMA

1

2

3

4

5

p (*)

Type II

13.6 ± 10.0

14.9 ± 11.4

15.5 ± 11.1

16.0 ± 11.2

16.9 ± 10.6

0.031

Type III

24.9 ± 3.4

24.8 ± 3.3

24.4 ± 3.5

24.4 ± 3.5

24.1 ± 3.9

0.961

p (**)

0.006

0.016

0.029

0.039

0.051

 
  1. * Comparison between the first evaluation with the subsequent ones
  2. ** Comparison between both groups (type II and III) in each evaluation
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us